Expression of interest: GP input into protocols being developed for the Community Pharmacist Program

July 24, 2026

The Victorian Department of Health is seeking input from general practitioners to review clinical protocols being developed for the Community Pharmacist Program (the Program). 

About the program

The Program is a statewide initiative that enables trained community pharmacists to administer, supply and sell specified Schedule 4 medications without a prescription, for select conditions. To support this, pharmacists in the Program must follow clinical protocols for each service.

Each clinical protocol is developed with input from a range of clinical and subject matter experts to ensure that services under the program are safe and appropriate for Victorian patients. GP input into the protocols supports both the clinical aspects of the protocol and the collaborative relationship between the pharmacist and general practice. 

What's involved?

The Program is expanding to include 23 health and wellbeing conditions by June 2027, and the Program is seeking support from general practitioners to review and provide input on the draft clinical protocols for the conditions below.

Feedback will be sought through either meetings or workshops, and GPs will be remunerated for their time. The time commitment is approximately one hour, depending on the protocol. After hours consultation can be facilitated.

Proposed conditions 

Planned for release in 2026 Planned for release in 2027
GORD Acute otitis media
Allergic rhinitis Acute otitis externa
Acute nausea and vomiting (from Gastroenteritis) Acute minor wound management
Management for Overweight and Obesity Asthma
Dental COPD review
Smoking cessation COPD exacerbation
Hypertension
Dyslipidaemia
Diabetes (T2DM)

How to express your interest

To express interest in this opportunity, please email the Program Expansion team at CPPExpansion@health.vic.gov.au with the following details:

  • Name
  • Position title
  • Condition/s that you would be interested in contributing to

Please also feel free to reach out to the Program team if you have any questions about the Program via the same email address.


Express your interest

Latest news

Key information for providers: Capvaxive® vaccine supply and availability

August 12, 2026
Recent vaccine supply and distribution issues have caused temporary vaccine shortages of the Capvaxive ® (pneumococcal) vaccine.

Supporting dementia prevention in primary care

August 12, 2026
Throughout July and August, all Australians aged 50 will receive a letter, from the Australian Government Department of Health, Disability and Ageing, about reducing their dementia risk. Some patients may bring the letter or a dementia risk assessment report to appointments to ask questions or seek support.

Mental Health & Better Access Quality Improvement - Activity 5

August 7, 2026
The purpose of this activity is to ensure patients with a mental health diagnosis (particularly high-risk mental health patients, e.g. bipolar disorder and a Mental Health Treatment Plan) that require phone (level C or D) and/or videoconference longer appointments (level C, D or E) are identified and proactively offered MyMedicare registration supporting continuity of care and improved outcomes.